MEDICAL CANNABIS PHARMA - EVOLUTION OR REVOLUTION

MEDICAL CANNABIS HEALTHCARE EVOLUTION OR REVOLUTION? [logo] WHY INVEST NOW? ✓ Founded in 2019 by an experienced Management Team ✓ 100% natural and offers significant therapeutic benefits ✓ Physical presence in Portugal, Lesotho, South Africa & Colombia ✓ The industry will more than double in size in the next five years. CANNABIS THERAPEUTICS SECTOR Savvy investors understand the significance of incorporating social, environmental, and corporate governance (ESG) investments into their portfolios. Over the last 3 to 5 years, the alternative medical Cannabis Therapeutics Sector has been uniquely linked to these values. Investors are increasingly applying these non-financial factors to their analysis in determining material risks and growth opportunities. [logo] [logo] [logo] [logo] [REQUEST INFORMATION DOCUMENT]( HEALTHCARE REVOLUTION So why now? The sector is now beginning to recognise its full potential. The industry will more than double in size over the next five years. Estimates foresee the legalised market size across Europe reaching 89 million users. Mother nature’s powerful plant provides patients with a viable alternative to big pharmaceutical healthcare with the treatment of Epilepsy, Multiple Sclerosis and ADHD, as well as many other conditions. It is also well documented that its sister leaf “Hemp” is the only perennial renewable natural resource capable of supplying the world’s paper, textile, transportation, and energy needs while reducing pollution, rebuilding the soil, and cleansing the atmosphere. Our latest Information Document will give you an insight into why this natural plant is changing our approach to healthcare. [GET IN TOUCH]( Disclaimer: Any person accessing the email and considering potential investment opportunities featured in the email should make their own commercial assessment after seeking the advice of an appropriately authorised or regulated financial advisor. This email should not be construed as advice or a personal recommendation to any prospective investor. Investments of this nature carry risks to your capital and can go up or down. Past performance is not indicative of future results. This opportunity is only suitable for high net worth or self-sophisticated investors as defined; you will have an annual income in excess of £100K. Have net assets in excess of £250K beyond your pension fund assets and your private residence. You have been a Director of a company turning over at least £1 million within the last two years. You have made more than one investment in an unlisted company in the previous two years. You have been a member of a network or syndicate of business angels for at least six months. You have worked in the past two years in a professional capacity in the private equity sector or in the provision of finance for small and medium enterprises. ADVFN Disclaimer Although ADVFN has sent you this email on behalf of an advertiser, this is not an ADVFN product. ADVFN does not endorse this product or the company providing it nor is it responsible for the content of this advertisement. We have not reviewed the information; claims or testimonials provided within the advertisement and make no guarantee or warranty regarding its content. The opinions and recommendations expressed in this email advertisement are not those of ADVFN and ADVFN offers none in any event. --------------------------------------------------------------- [View Online]( [Add us to your address book]( [Unsubscribe]( from ADVFN commercial emails --------------------------------------------------------------- Registered Office/Accounts Dept: 28 Ongar Business Centre, The Gables, Fyfield Road, Ongar, Essex, CM5 0GA. Support Tel: +44 (0) 203 8794 460 Company registered in England and Wales: Number 2374988 VAT No: GB 549 2130 49